logo
Select company
Select metric
28.65%Cash to Assets Ratio
VS
Market
83
Sector
57
Industry
44
History
46
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

IGMS

Company Name

IGM BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IGM BIOSCIENCES INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IGMS - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 106.99M$ 30.65M28.65%
3/31/2025$ 206.89M$ 36.88M17.83%
12/31/2024$ 265.71M$ 26.66M10.03%
9/30/2024$ 304.51M$ 43.06M14.14%
6/30/2024$ 336.5M$ 67.26M19.99%
3/31/2024$ 376.13M$ 79.5M21.14%
12/31/2023$ 423.41M$ 113.11M26.71%
9/30/2023$ 474.35M$ 175.41M36.98%
6/30/2023$ 480.66M$ 151.34M31.49%
3/31/2023$ 462.74M$ 140.82M30.43%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IGM BIOSCIENCES INC's latest trailing twelve months (TTM) Cash to Assets stands at 12.89%.
  • Over the past 5 years, IGM BIOSCIENCES INC's average Cash to Assets has been 33.25%.
  • The median Cash to Assets for IGM BIOSCIENCES INC during this period was 29.98%
  • IGM BIOSCIENCES INC reached its highest Cash to Assets over the past 5 years at 70.17%.
  • The lowest Cash to Assets recorded by IGM BIOSCIENCES INC in the same timeframe 10.03%

IGM BIOSCIENCES INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
ATRA : ATARA BIOTHERAPEUTICS INC 45.81%CHRS : COHERUS ONCOLOGY INC 49.35%STRO : SUTRO BIOPHARMA INC 24.73%MGNX : MACROGENICS INC 53.25%IPSC : CENTURY THERAPEUTICS INC 20.93%KPTI : KARYOPHARM THERAPEUTICS INC 37.26%DOMH : DOMINARI HOLDINGS INC 8.66%ZYXI : ZYNEX INC 20.89%FBIO : FORTRESS BIOTECH INC 47.28%MGX : METAGENOMI INC 11.79%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for IGM BIOSCIENCES INC is calculated as follows: CashnEq [ $ 27.28M ] / Assets [ $ 211.72M ]
(=) Cash to Assets [ 12.89% ]

IGMS - Cash to Assets Ratio, Last 5 years

10.03%

Minimum

Dec 31, 2024

70.17%

Maximum

Jun 30, 2021

33.25%

Average

29.98%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%